AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?
Tóm tắt
Kaposi Sarcoma (KS) is a malignancy of endothelial skin cells with multifocal localization on the skin, lymph nodes and visceral organs. Although all clinical variants are associated with HHV-8 infection, specific differences in the clinical onset and in the natural history of AIDS-KS and Classic-KS have been described. The present randomised prospective-observational study aimed to investigate whether the ultrasound pattern and color Doppler flow imaging of vascularisation of skin lesions of patients with Classic KS (CKS) or AIDS-KS could provide useful information to the evaluation of clinical activity of the disease. Cutaneous lesions of 24 patients with histologically confirmed KS were investigated using very high frequency ultrasound probes; 16 patients had CKS and 8 had AIDS-KS. HHV-8 infection was confirmed in all patients by investigating the specific humoral response to viral antigens. Immunological and virological parameters were also assessed to monitor HIV or HHV-8 viral infection. For each patient, a target skin lesion was selected on the basis of size (diameter from 0.4 to 2 cm). Each lesion was analyzed in terms of size, depth and color Doppler pattern. The B-mode ultrasound patterns of skin lesions did not differ when comparing CKS patients to AIDS-KS patients, whereas the color Doppler signal, which is associated with vascular activity, was detected in the KS lesions of 6/8 AIDS-KS patients (75.0%) and in 2/16 CKS (16,7%); the latter two patients showed a clinically progressive and extensive disease stage (IV B). Our preliminary results suggest that small cutaneous KS lesions - in both CKS and AIDS-KS patients- display similar B-mode ultrasound patterns ( hypoechoic, well defined, superficial lesions). However, the color Doppler signal, which is associated with endothelial activity and angiogenesis, which play a substantial role in KS progression, could constitute a useful tool for evaluating disease activity.
Tài liệu tham khảo
Mesri EA, Cesarman E, Boshoff C: Kaposi's sarcoma and its associated herpesvirus. Nat rev cancer. 2010, 10: 707-719. 10.1038/nrc2888.
Tornesello ML, Biryahwaho B, Downing R, Hatzakis A, Alessi E, Cusini M, Ruocco V, Katongole-Mbidde E, Loquercio G, Buonaguro L, Buonaguro FM: Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology. 2010, 398: 280-289. 10.1016/j.virol.2009.12.005.
CDC: Revision of the case definition of AIDS for national reporting. MMWR. 1985, 4: 373-374.
Lanternier F, Lebbé C, Schartz N, Farhi D, Marcelin AG, Kérob D, Agbalika F, Vérola O, Gorin I, Janier M, Avril MF, Dupin N.: Kaposi's sarcoma in HIV-negative men having sex with men. AIDS. 2008, 22: 1163-1168. 10.1097/QAD.0b013e3283031a8a.
Giuliani M, Cordiali-Fei P, Castilletti C, Di Carlo A, Palamara G, Boros S, Rezza G: Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections. BMC Infect Dis. 2007, 7: 143-151. 10.1186/1471-2334-7-143.
Gessain A, Duprez R: Spindle cells and their role in Kaposi's sarcoma. Int J Biochem Cell Biol. 2005, 37: 2457-2465. 10.1016/j.biocel.2005.01.018.
Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ: Epidemiology, pathophysiology and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis. 2008, 47: 1209-1215. 10.1086/592298.
Brambilla L, Boneschi V, Taglioni M, Ferrucci S: Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2001, 13: 83-86.
Kriegel RL, Laubenstein LJ, Muggia FM, Kaposi's sarcoma: A new staging classification. Cancer Treat Rep. 1983, 67: 531-534.
Stebbing J, Sanitt A, Nelson M, Pawles T, Gazzard B, Bower M: A prognostic index for AIDS-associated Kaposi's sarcoma in the era of higly active antiretroviral therapy. Lancet. 2006, 367: 1495-1502. 10.1016/S0140-6736(06)68649-2.
Boneschi V, Brambilla L, Berti E, Ferrucci S, Corbellino M, Parravicini C, Fossati S: Human Herpesvirus- 8 DNA in the skin and blood of patients with Mediterranean kaposi's Sarcoma: clinical correlations. Dermatology. 2001, 203: 19-23. 10.1159/000051697.
Brambilla L, Labianca R, Ferrucci SM, Taglioni M, Boneschi V: Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology. 2001, 202: 119-122. 10.1159/000051610.
Brambilla L, Boneschi V, Fossati S, Melotti E, Clerici M: Oral etoposide for Kaposi's Mediterranean sarcoma. Dermatologica. 1988, 177: 365-369. 10.1159/000248608.
Lauriola C, Bergonzini R: The value of thermography and lymphography in the diagnosis and follow-up of Kaposi's disease. Rays. 1985, 10: 85-90.
Mahoney SE, Paddock SW, Smith LC, Lewis DE, Duvic M: Three-dimensional laser- scanning confocal microscopy of in situ hybridization in the skin. Am J Dermatopathol. 1994, 16: 44-51. 10.1097/00000372-199402000-00009.
Schmid-Wendtner MH, Dill-Müller D: Ultrasound technology in dermatology. Semin Cutan Med Surg. 2008, 27: 44-51. 10.1016/j.sder.2008.01.003.
Wong S, Kaur A, Back M, Lee KM, Baggarley S, Lu JJ: An ultrasonographic evaluation of skin thickness in breast cancer patients after postmastectomy radiation therapy. Radiat Oncol. 2011, 6: 9-10.1186/1748-717X-6-9.
Bogner JR, Zietz C, Held M, Spatling S, Sandor P, Kronawitter U, Goebel FD: Ultrasound as a tool to evaluate remission of cutaneous Kaposi's sarcoma. J Acquir Immune Defic Syndr. 1993, 6 (5): 530-531. 10.1097/00126334-199305000-00015.
Wang Y, Dan HJ, Fan JH, Wen S-B: Evaluation of the correlation between Colour Power Doppler Flow Imaging and Vascular Endothelial Growth Factor in breast cancer. J Int Med Res. 2010, 38: 1077-1083.
Bertolini F, Mancuso P, Shaked Y, Kerbel RS: Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discovery Today. 2007, 12: 806-812. 10.1016/j.drudis.2007.08.011.
Kalof AN, Cooper K: D2-40 Immunochemistry-so far. Adv Anat Pathol. 2009, 16: 62-64. 10.1097/PAP.0b013e3181915e94.
Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Buttò S, Lodi G, Di Carlo A, Levi JA, Ensoli B: Prevalence and determinants of anti-lytic and andi-latent antibodies to human herpes virus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer. 1998, 77: 361-365. 10.1002/(SICI)1097-0215(19980729)77:3<361::AID-IJC9>3.0.CO;2-M.
Cammarota T: Ecografia in Dermatologia. 1998, Poletto Editore, Milano
Barillari G, Ensoli B: Angiogenic effects of extracellular human immodeficiency virus type1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's Sarcoma. Clin Microbiol Rev. 2002, 15: 310-326. 10.1128/CMR.15.2.310-326.2002.
Pyakurel P, Pak F, Mwakigonja AR, Kaaya E, Biberfeld P: KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development. Infect Agent Cancer. 2007, 2: 2-4. 10.1186/1750-9378-2-4.